NDC 63629-8392 – Butalbital, Acetaminophen, and Caffeine

Butalbital 50 mg/1; Acetaminophen 325 mg/1; Caffeine 40 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CIII 1 recall

Product NDC63629-8392

Product details

Brand name
Butalbital, Acetaminophen, and Caffeine
Generic name
Butalbital, Acetaminophen, and Caffeine
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA200243
Marketed since
September 13, 2012
Listing expires
December 31, 2026
Pharmacologic class
Barbiturate; Central Nervous System Stimulant; Methylxanthine

Active ingredients

Uses, dosage, side effects and warnings for Butalbital, Acetaminophen And Caffeine →

Package NDC codes (10)

Package NDCDescriptionSince
63629-8392-084 TABLET in 1 BOTTLE (63629-8392-0)Oct 29, 2024
63629-8392-120 TABLET in 1 BOTTLE (63629-8392-1)Oct 29, 2024
63629-8392-230 TABLET in 1 BOTTLE (63629-8392-2)Dec 9, 2020
63629-8392-360 TABLET in 1 BOTTLE (63629-8392-3)Dec 9, 2020
63629-8392-490 TABLET in 1 BOTTLE (63629-8392-4)Jan 20, 2021
63629-8392-550 TABLET in 1 BOTTLE (63629-8392-5)Oct 29, 2024
63629-8392-66 TABLET in 1 BOTTLE (63629-8392-6)Oct 29, 2024
63629-8392-7120 TABLET in 1 BOTTLE (63629-8392-7)Oct 29, 2024
63629-8392-840 TABLET in 1 BOTTLE (63629-8392-8)Oct 29, 2024
63629-8392-912 TABLET in 1 BOTTLE (63629-8392-9)Dec 8, 2020

Recalls mentioning this NDC

Other Butalbital, Acetaminophen And Caffeine products